Retroperitoneal Teratoma with Secondary Infection.

J Coll Physicians Surg Pak

Department of Radiology, Alanya Alaaddin Keykubat University, Alanya Education and Research Hospital, Oba District, Alanya/Antalya, Turkey.

Published: August 2019

Teratomas are germ cell tumors arising from the embryonic germ layers. Since they originate from the germ cells, they can be found in the gonadal, sacrococcygeal, mediastinal, intracranial, retroperitoneal, and cervical regions. In this case report, a 4-year boy, brought to the hospital due to abdominal pain and fever, was diagnosed as a large and infected peritoneal teratoma by contrast-enhanced abdominal computed tomography (CT) along with abdominal CT and operative findings.

Download full-text PDF

Source
http://dx.doi.org/10.29271/jcpsp.2019.08.778DOI Listing

Publication Analysis

Top Keywords

retroperitoneal teratoma
4
teratoma secondary
4
secondary infection
4
infection teratomas
4
teratomas germ
4
germ cell
4
cell tumors
4
tumors arising
4
arising embryonic
4
embryonic germ
4

Similar Publications

Germ cell tumors, the most common of the testicular neoplasms, originate from primordial germ cells. These tumors are known for their totipotent nature, capable of differentiating into various cell types. This case report presents a rare occurrence of mucinous cystadenoma in a patient who received chemotherapy for metastatic left non-seminomatous germ cell tumor (NSGCT) of the testis.

View Article and Find Full Text PDF

Teratomas are germ cell tumors that arise from the derivatives of the three germ cell layers. They are categorized into subtypes by the extent of maturation, with mature teratomas being the most common subtype. While they can arise in various extragonadal regions, including the retroperitoneum, their occurrence in the retroperitoneal space is extremely rare.

View Article and Find Full Text PDF

A predictive system comprising serum microRNAs and radiomics for residual retroperitoneal masses in metastatic nonseminomatous germ cell tumors.

Cell Rep Med

December 2024

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China. Electronic address:

Predicting the histopathology of residual retroperitoneal masses (RMMs) before post-chemotherapy retroperitoneal lymph node dissection in metastatic nonseminomatous germ cell tumors (NSGCTs) can guide individualized treatment and minimize complications. Previous single approach-based models perform poorly in validation. Herein, we introduce a machine learning model that evolves from a single-dimensional tumor diameter to incorporate high-dimensional radiomic features, with its effectiveness assessed using the macro-average area under the receiver operating characteristic curves (AUCs).

View Article and Find Full Text PDF

Objectives: To reassess the role of primary retroperitoneal lymph node dissection (RPLND) in patients with marker-negative non-seminomatous germ cell tumour (NSGCT) clinical stage (CS) 2a, to explore results in patients with CS 2b and to evaluate surgical methods, recurrence, and adjuvant chemotherapy indications.

Materials And Methods: Data from 17 institutions were collected, comprising 305 men who underwent primary RPLND for CS 2 NSGCT. Regression analyses were conducted to predict histology in the RPLND specimen and disease-free survival (DFS).

View Article and Find Full Text PDF
Article Synopsis
  • - The study examined the outcomes of laparoscopic retroperitoneal lymph node dissection (RPLND) in post-chemotherapy patients with nonseminomatous testicular germ-cell tumors at Kyushu University Hospital between 2016 and 2024.
  • - A total of 13 patients participated, with median tumor sizes of 11 mm, and the procedure showed low median blood loss (27 mL) and no severe complications.
  • - The results indicate that laparoscopic RPLND is a safe and effective minimally invasive option for selected patients, with no recurrence noted during a median follow-up of 18.6 months.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!